Oncology & Cancer

Stereotactic body RT promising for low-, intermediate-risk PCa

(HealthDay)—In men with low-risk and intermediate-risk prostate cancer, stereotactic body radiotherapy is associated with low rates of severe toxic events and high rates of biochemical control, according to a study published ...

Oncology & Cancer

Targeted hope for metastatic cancer

A cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spread through the body has often been considered a death sentence.

page 13 from 39